Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Exanthema × Gels × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parapsoriasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Exanthema 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

benralizumab 1 Sirolimus 1 Gels 1 Fulvestrant 1 Fibroblast Growth Factor 7 1 Dapsone 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00343187 2011-05-30

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Allergan

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡